NCT02587988

Trial to Evaluate the Efficacy and Safety of HCP1302

A Randomized, Double-blind, Multicenter, Phase Ⅲ Study to Evaluate the Efficacy and Safety of HCP1302 in Both Erectile Dysfunction and Hypertension Patients Being Treated With HGP0904

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 232 (actual)
• Sponsor: Hanmi Pharmaceutical Company Limited · Industry
• Sex: Male
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

Trial to Evaluate the Efficacy and Safety of HCP1302

Detailed description

A Randomized, Double-blind, Multicenter, Phase Ⅲ study to Evaluate the Efficacy and Safety of HCP1302 in Both Erectile Dysfunction and Hypertension Patients being Treated with HGP0904

Conditions

• Erectile Dysfunction
• Hypertension

Interventions

Type	Name	Description
DRUG	HCP1302
DRUG	HGP0904
DRUG	Placebo (for HCP1302)
DRUG	Placebo (for HGP0904)

Timeline

• Start date: 2014-09-01
• Primary completion: 2015-05-01
• Completion: 2015-08-01
• First posted: 2015-10-27
• Last updated: 2016-11-01